Celina Ang

2.8k citations

51 papers · 956 indexed · h-index 16

Impact in

Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Cancer Research top 10%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Hepatology 21
- Hepatocellular Carcinoma Treatment and Prognosis 19
Oncology 21
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 6
- Inflammatory Biomarkers in Disease Prognosis 4

Co-authors: Randall F. Holcombe (4 shared papers)Umut Özbek (9 shared papers)Sherri Z. Millis (6 shared papers)Ghassan K. Abou‐Alfa (8 shared papers)Erin Moshier (2 shared papers)Myron Schwartz (3 shared papers)Jeffrey S. Ross (3 shared papers)Eileen M. O’Reilly (8 shared papers)
Journals: Journal of Clinical Oncology (14 papers)Annals of Oncology (3 papers)Oncotarget (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)JCO Precision Oncology (2 papers)
Partner nations: United States Italy United Kingdom

In The Last Decade

Celina Ang

49 papers receiving 939 citations

Peers

Countries citing papers authored by Celina Ang

Since Specialization

Citations

This map shows the geographic impact of Celina Ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celina Ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celina Ang more than expected).

Fields of papers citing papers by Celina Ang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celina Ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celina Ang. The network helps show where Celina Ang may publish in the future.

Co-authors

The 25 scholars most cited alongside Celina Ang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Celina Ang Line = papers co-authored together Celina Ang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma Oncotarget ·Celina Ang, Samuel J. Klempner, Siraj M. Ali, Russell W. Madison, Jeffrey S. Ross, Eric A. Severson, David Fabrizio, Aaron M. Goodman, Razelle Kurzrock, James Suh, Sherri Z. Millis	2019	125
2	Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study Cancer Chemotherapy and Pharmacology ·Sofya Pintova, Sirish Dharmupari, Erin Moshier, Nicole Zubizarreta, Celina Ang, Randall F. Holcombe	2019	92
3	A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma Oncogene ·Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola, Amanda J. Craig, Johann von Felden, Sebastião N. Martins-Filho, Daniela Sia, Ashley Stueck, Stephen C. Ward, Maria Isabel Fiel, Milind Mahajan, Parissa Tabrizian, Swan N. Thung, Celina Ang, Scott L. Friedman, Josep M. Llovet, Myron Schwartz, Augusto Villanueva	2018	89
4	Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy Cancer Medicine ·Sirish Dharmapuri, Umut Özbek, Jung‐Yi Lin, Max W. Sung, Myron Schwartz, Andrea D. Branch, Celina Ang	2020	82
5	Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. PubMed ·Celina Ang, Robin Katie Kelley, Michael A. Choti, David Cosgrove, Joanne F. Chou, David S. Klimstra, Michael Torbenson, Linda D. Ferrell, Timothy M. Pawlik, Yuman Fong, Eileen M. O’Reilly, Jennifer Ma, Joseph McGuire, Gandhi P. Vallarapu, A. Clark Griffin, Francesco Stipa, Marinela Capanu, Ronald P. DeMatteo, Alan P. Venook, Ghassan K. Abou‐Alfa	2013	78
6	Genomic Landscape of Appendiceal Neoplasms JCO Precision Oncology ·Celina Ang, John Paul Shen, Camille J. Hardy-Abeloos, Justin K. Huang, Jeffrey S. Ross, Vincent A. Miller, Miriam T. Jacobs, Ingrid L. Chen, David Xu, Siraj Ali, Joel Baumgartner, Andrew M. Lowy, Paul T. Fanta, Trey Ideker, Sherri Z. Millis, Olivier Harismendy	2018	62
7	Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States Gastric Cancer ·Brian De, Ryan Rhome, Vikram Jairam, Umut Özbek, Randall F. Holcombe, Michael Buckstein, Celina Ang	2018	49
8	Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling Cancer Discovery ·Christos Adamopoulos, Tamer A. Ahmed, Maxwell R. Tucker, Peter M.U. Ung, Min Xiao, Zoi Karoulia, Angelo Amabile, Xuewei Wu, Stuart A. Aaronson, Celina Ang, Vito W. Rebecca, Brian D. Brown, Avner Schlessinger, Meenhard Herlyn, Qi Wang, David E. Shaw, Poulikos I. Poulikakos	2021	40
9	A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT). Journal of Clinical Oncology ·Anna M. Varghese, Celina Ang, Christopher J. DiMaio, Milind Javle, Martin Gutierrez, Nirit Yarom, Salomon M. Stemmer, Talia Golan, Ravit Geva, Valeriya Semenisty, Iyad Khamaysi, Rosario Ligresti, Shay Rotkopf, Racheli Gabai-Malka, Eithan Galun, Amotz Shemi, Mark Schattner, Eileen M. O’Reilly	2020	36
10	A Review of Coronary Artery Disease Research in Malaysia. PubMed ·Celina Ang, K M J Chan	2016	34
11	Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options Journal of Surgical Oncology ·Celina Ang, John T. Miura, T. Clark Gamblin, Ruth He, Joanne Xiu, Sherri Z. Millis, Zoran Gatalica, Sandeep K. Reddy, Nelson S. Yee, Ghassan K. Abou‐Alfa	2015	25
12	Targeted Agents and Systemic Therapy in Hepatocellular Carcinoma Recent results in cancer research ·Celina Ang, Eileen M. O’Reilly, Ghassan K. Abou‐Alfa	2012	19
13	CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients British Journal of Radiology ·Richard Kinh Gian, Aoife McErlean, Celina Ang, Ronald P. DeMatteo, Ghassan K. Abou‐Alfa	2014	18
14	A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma The Oncologist ·Imane El Dika, Robert J. Mayer, Alan P. Venook, Marinela Capanu, Michael P. LaQuaglia, Rachel Kobos, Allison F. O’Neill, Joanne F. Chou, Michele Ly, Celina Ang, Eileen M. O’Reilly, John D. Gordan, Ghassan K. Abou‐Alfa	2020	17
15	Role of the fibroblast growth factor receptor axis in cholangiocarcinoma Journal of Gastroenterology and Hepatology ·Celina Ang	2015	15
16	Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma JCO Oncology Practice ·Kathryn E. Marqueen, Edward Kim, Celina Ang, Madhu Mazumdar, Michael Buckstein, Bart S. Ferket	2021	15
17	Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease Clinical Colorectal Cancer ·Jordan E. Axelrad, Anuja Kriplani, Umut Özbek, Noam Harpaz, Jean‐Frédéric Colombel, Steven H. Itzkowitz, Randall F. Holcombe, Celina Ang	2016	14
18	Lynch Syndrome–Associated Variants and Cancer Rates in an Ancestrally Diverse Biobank JCO Precision Oncology ·Rachel Rosenblum, Celina Ang, Sabrina A. Suckiel, Emily R. Soper, Meenakshi Sigireddi, Sinéad Cullina, Gillian M. Belbin, Aimee L. Lucas, Eimear E. Kenny, Noura S. Abul‐Husn	2020	13
19	c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. PubMed ·Celina Ang, Mark Y. Sun, D. Huitzil-Meléndez, Joanne F. Chou, Marinela Capanu, William R. Jarnagin, Yuman Fong, Ronald P. DeMatteo, Michael I. D’Angelica, Peter J. Allen, Chin‐Tung Chen, Eileen M. O’Reilly, Martin R. Weiser, Ghassan K. Abou‐Alfa	2013	13
20	Modification to reporting of qualitative fluorescent spot test results improves detection of glucose‐6‐phosphate dehydrogenase (G6PD)‐deficient heterozygote female newborns International Journal of Laboratory Hematology ·Veera Sekaran Nadarajan, Hemalatha Shanmugam, Pavai Sthaneshwar, S. JAYARANEE, Keith Sultan, Celina Ang, Sarasa Bharati Arumugam	2011	12

About Celina Ang

Celina Ang is a scholar working on Hepatology, Oncology, Cancer Research, Gastroenterology and Reproductive Medicine, having authored 51 papers that have together received 956 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (7 papers), Gastric Cancer Management and Outcomes (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). The work is most often cited by research in Hepatology (330 citations), Cancer Research (224 citations), Oncology (338 citations), Pathology and Forensic Medicine (170 citations) and Pulmonary and Respiratory Medicine (219 citations). Celina Ang has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Randall F. Holcombe, Umut Özbek, Sherri Z. Millis, Ghassan K. Abou‐Alfa, Erin Moshier, Myron Schwartz, Jeffrey S. Ross, Eileen M. O’Reilly, Nicole Zubizarreta and Michael Buckstein. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oncotarget, International Journal of Radiation Oncology*Biology*Physics and JCO Precision Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact